automated-news
FORM 8.3
automated-news
Economists had expected a slower pace of expansion
Even by the standards of this White House, last week was a lot. On Monday, President Donald Trump announced 50% tariffs on Canadian goods via a Depression-era statute that has never been used (and might be defunct). On Tuesday, he set a 100% tariff on generic drugs but delayed it until 2028. His tea
automated-news
FORM 8.3
automated-news
Personalized astrology app Soulloop acquires multilingual conversational platform Astrolumi.AI, expanding its reach internationally through WhatsApp.
Federal Reserve Chair Kevin Warsh kicked off his second post-decision press conference with a familiar refrain: Inflation has been running above the central bank’s 2% objective for too long, and he’s resolute about fixing it. “You’ve heard this before, but we will deliver price stability,” he said.
Starbucks Corp. is hot again.
automated-news
IonQ getting approval for SkyWater acquisition should improve its roadmap: Wedbush
automated-news
Intercontinental Exchange to acquire MarketAxess in $6B deal
Braveheart Bio Inc., a clinical-stage biopharmaceutical company backed by a16z, is seeking to raise as much as $318.8 million in an initial public offering, adding to a growing pipeline of listings in the sector.